Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nyse  >  Pfizer    PFE

PFIZER (PFE)
My previous session
Most popular
  Report  
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
 Analysis summaryMarketScreener Strategies
OFFRE
Strengths
  • The group's activity appears highly profitable thanks to its outperforming net margins.
  • The company is one of the best yield companies with high dividend expectations.
  • Within the weekly time frame the stock shows a bullish technical configuration above the support level at 39.01 USD
Weaknesses
  • Stock prices approach a strong long-term resistance in weekly data at USD 46.
  • According to Thomson-Reuters' forecast, revenue growth prospects are expected to be very low for the next fiscal years.
  • Based on current prices, the company has particularly high valuation levels.
  • The three month average target prices set by analysts do not offer high potential in comparison with the current prices.
Ratings chart
Sector Pharmaceuticals - NEC
1st jan.Capitalisation (M$)Investor Rating
PFIZER21.65%258 285
JOHNSON & JOHNSON1.62%383 312
NOVARTIS-0.63%216 108
ROCHE HOLDING LTD.-4.60%211 501
MERCK AND COMPANY25.79%189 092
AMGEN17.94%132 756
ABBOTT LABORATORIES20.54%121 136
ELI LILLY AND COMPANY25.89%114 197
SANOFI3.69%109 540
BRISTOL-MYERS SQUIBB COMPAN..0.77%101 584
GLAXOSMITHKLINE15.80%99 260
ASTRAZENECA10.72%92 763
NOVO NORDISK A/S-9.87%89 924
BAYER-25.23%83 828
ALLERGAN PLC17.69%64 939
CELGENE CORPORATION-15.39%61 699
More Results
Financials ($)
Sales 2018 54 227 M
EBIT 2018 20 582 M
Net income 2018 13 123 M
Debt 2018 24 897 M
Yield 2018 3,11%
P/E ratio 2018 19,64
P/E ratio 2019 18,11
EV / Sales 2018 5,22x
EV / Sales 2019 4,97x
Capitalization 258 B
Surperformance© ratings
  Help  
Fundamental ratings
Overall rating
Trading Rating
Investor Rating
Growth (Revenue)
Valuation
Finances
Profitability
Earnings quality
Business Predictability
P/E ratio
Potential
Yield
Consensus
7 days EPS revision
4 months EPS revision
1 year EPS revision
4 months Revenue revision
1 year Revenue revision
Technical ratings
Short Term Timing
Middle Term Timing
Long Term Timing
RSI
Bollinger Spread
Unusual Volumes
Chart PFIZER
Duration : Period : Day
Pfizer Technical Analysis Chart | MarketScreener
Duration : Period : Week
Pfizer Technical Analysis Chart | MarketScreener